Condition
Familial Cold Urticaria
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06544018Not ApplicableRecruiting
Circadian Rhythm Deregulation in Patients With CAPS
NCT00214851Phase 1CompletedPrimary
The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
NCT00288704Phase 3Completed
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Showing all 3 trials